melphalan
- n antineoplastic drug (trade name Alkeran) used to treat multiple myeloma and some other malignancies
melphalan :
Search Words
News & Articles
- Ligand’s Partner Spectrum Pharmaceuticals Reports Captisol-Enabled Melphalan Meets Primary Endpoint in Pivotal Trial
Ligand Pharmaceuticals Incorporated announces that its Captisol-enabled™ Melphalan development and commercial partner Spectrum
April 23, 2014 - Business Wire via Yahoo! Finance - Ligand's partner Spectrum says Captisol-enabled melphalan meets primary endpoint
Ligand Pharmaceuticals (LGND) announces that its Captisol-enabled Melphalan development and commercial partner Spectrum Pharmaceuticals (SPPI) has reported that their pivotal trial of CE Melphalan met ...
April 23, 2014 - theflyonthewall.com via Yahoo! Finance - CE Melphalan meets Phase 2 primary endpoint
Spectrum Pharmaceuticals' ( SPPI ) conditioning treatment in autologous transplants in multiple myeloma, Captisol-enabled (propylene glycol-free) Melphalan ( CE Melphalan ) meets its primary endpoint of determining the overall safety and toxicity profile in multiple myeloma patients receiving 200mg/m2 of CE Melphalan as myeloablative therapy prior to autologous stem cell transplantation ...
April 23, 2014 - Seeking Alpha